Alnylam Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.

About ALNY

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference.

CEO

Yvonne L. Greenstreet

CEOYvonne L. Greenstreet

Employees

2,230

Employees2,230

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2002

Founded2002

Employees

2,230

Employees2,230

ALNY Key Statistics

Market cap

38.22B

Market cap38.22B

Price-Earnings ratio

-136.44

Price-Earnings ratio-136.44

Dividend yield

—

Dividend yield—

Average volume

892.60K

Average volume892.60K

High today

$293.21

High today$293.21

Low today

$284.80

Low today$284.80

Open price

$287.65

Open price$287.65

Volume

965.13K

Volume965.13K

52 Week high

$304.39

52 Week high$304.39

52 Week low

$146.79

52 Week low$146.79

Analyst ratings

71%

of 35 ratings

Buy

71.4%

Hold

25.7%

Sell

2.9%

People also own

Based on the portfolios of people who own ALNY. This list is generated using Robinhood data, and it’s not a recommendation.

Vertex Pharmaceuticals